Transcarent agreed to acquire healthcare company Accolade for $7.03 a share in cash, bringing the equity value of the deal to around $621 million.

Follow along with WSJ for live updates on stocks, bonds and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.

Stock futures were wavering between slight gains and losses on Wednesday morning as investors digested fresh labor market data.

The US indices in the premarket session continue to see pressures form yields in the bond market rising. Overnight, we have seen the ten year yield reach the 4.7% level, making it difficult for stock ...

Canadian authorities "will collect billions in capital gains taxes, with no legislation authorizing it, until a government officially tells it to stop. This means that it could be a long time before ...

Drug discovery is a key area for AI, given the speed at which models trained on massive datasets can tackle a variety of tasks. Last year, Nvidia said it was doubling down on AI-powered drug discovery ...

But maybe of more use are the hedges the company with $11 trillion in assets has articulated for a number of concerns that are currently weighing on investors' minds, according to strategists led by ...